UBS O'Connor’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-537,388
Closed -$18.5M 934
2014
Q4
$18.5M Buy
+537,388
New +$17.5M 0.32% 87
2013
Q3
Sell
-110,000
Closed -$1.83M 645
2013
Q2
$1.83M Buy
+110,000
New +$1.76M 0.03% 331

Other funds holding AUXL

UBS O'Connor's AUXL Position: Q1 2015 in Review

UBS O'Connor sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q1 2015, closing a stake of 537,388 shares — an estimated $18.5M sold.

UBS O'Connor first reported a position in AUXL in Q2 2013 and held it in 2 quarters. The position peaked at $18.5M in Q4 2014. 1 fund tracked by Wall St. Rank holds AUXL as of Q1 2015.

  • UBS O'Connor reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • UBS O'Connor sold 537,388 AUXILIUM PHARAMCEUTICALS INC shares in Q1 2015, an estimated $18.5M.
  • UBS O'Connor first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q2 2013 and held it in 2 quarters.
  • UBS O'Connor's AUXILIUM PHARAMCEUTICALS INC position peaked at $18.5M in Q4 2014.
  • 1 fund tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q1 2015.

Based on UBS O'Connor's 13F filing for Q1 2015, filed 14 May 2015.